封面
市場調查報告書
商品編碼
1198538

外科影像市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Surgical Imaging Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計手術影像市場在預測期內的複合年增長率為 6.1%。

在 COVID-19 流行初期,對污染風險的擔憂顯著減少了全球提供的醫學成像服務的數量,以及放射性示蹤劑等某些成像劑的供應不足。這對市場增長產生了重大影響。 例如,根據 2021 年 11 月在 PubMed 上發表的一篇論文,COVID-19 流行病顯著減少了放射成像和程序。 放射服務的總體下降取決於鎖定階段/持續時間、位置和成像方式。 同一消息來源報告稱,超聲檢查減少了 76%,MRI 檢查減少了 74%,乳房 X 光檢查減少了 66%。 然而,在後疫情形勢下,隨著限制解除,手術影像技術的進步和慢性病診斷影像的需求,市場需求正在增加。

在過去十年中,需要進行嚴重診斷的多種慢性病的患病率有所增加。 外科重症監護病房的患者經常接受實驗室和影像學檢查。 特別是一些慢性病,如高血壓、糖尿病、肥胖症和抑鬱症,在住院期間需要重症監護。 預計心血管疾病的高患病率將增加對外科影像服務的需求,從而推動市場增長。 例如,根據 BHF 的 2022 UK Factsheet,截至 2022 年 8 月,英國有超過 760 萬人患有心髒病和心血管疾病。 資料單顯示,心髒病和心血管疾病每年花費超過 90 億歐元(76 億美元)。 此外,受心血管疾病影響的大量人口以及隨之而來的高額年度醫療費用預計將在預測期內推動研究市場的增長。 慢性阻塞性肺病 (COPD) 是一種呼吸系統疾病,是肺部的慢性炎症,會抑制肺部的氣流。 這種疾病通常在胸部 X 光、CT 和磁共振成像 (MRI) 的幫助下診斷。 據英國下議院2021年11月發布的一份調查報告顯示,英國有超過117萬人被診斷患有慢性阻塞性肺病,約佔人口的1.9%。 受 COPD 影響的龐大人口將增加對手術影像服務的需求,以進行適當的治療和管理,從而推動預測期內的市場增長。

此外,與手術成像領域相關的產品發布、競爭對手的存在、併購可能會在預測期內推動市場增長。 例如,2022 年 7 月,西門子 Healthineers 宣布推出 ARTIS icono ceiling,這是一種吊頂式 C 臂血管造影系統,專為介入放射學 (IR) 和心髒病學的廣泛常規和高級程序而設計,並獲得了 FDA 的批准。 此外,2022 年 4 月,醫療技術和數字解決方案的創新者 Wipro GE Healthcare 推出了下一代 CT(計算機斷層掃描)掃描儀 Revolution Aspire。 Revolution Aspire 是根據“Atmanirbhar Bharat”倡議在新啟動的 Wipro GE 醫療設備製造廠中端到端設計和製造的。 因此,與手術影像領域相關的此類產品的推出有望在預測期內推動市場增長。

因此,由於慢性病的增加和對微創手術的需求增加,預計手術成像市場在預測期內將會增長。 然而,高昂的程序和設備成本以及嚴格的監管準則預計將限制預測期內的市場增長。

外科影像市場趨勢

手術影像市場預計在預測期內移動 C 臂部分將快速增長

移動式 C 臂是一種使用 X 射線技術的醫學成像設備,可用於診所內的各種手術室。 它源於連接X射線源和X射線探測器的C形臂。 C 形臂的一大優勢是它可以在患者周圍移動以獲得最佳角度,以獲得高圖像質量和患者舒適度。 這使其成為成本受限的小型醫院的理想選擇。

慢性病患病率上升和微創手術需求增加等因素似乎正在推動市場增長。 例如,根據 Blast Cancer.org 的 2022 年更新,美國約有 13%(約八分之一)的女性可能在 2022 年患上浸潤性乳腺癌。 根據同一消息來源,估計到 2022 年,美國女性將診斷出 287,850 例浸潤性乳腺癌新病例,以及 51,400 例非浸潤性(原位)乳腺癌新病例。 因此,越來越多的慢性病例將增加對移動 C 型臂的需求,這將推動預測期內的市場增長。

此外,移動 C 臂領域主要參與者的存在、併購和產品發布可能會在預測期內推動市場增長。 例如,2022 年 1 月,Philips將基於雲的人工智能和 3D 映射集成到其移動 C 臂系統系列“Zenition”中,以簡化工作流程並改善血管內治療結果。 此外,2021 年 6 月,Turner Imaging Systems 的便攜式熒光透視 X 射線成像設備“Smart-C Mini C-Arm”獲得了 CE 標誌。 因此,預計Smart-C這種具有出色便攜性的迷你C臂不僅可以在英國銷售,還可以在歐盟國家銷售。

因此,由於慢性病的增加和對微創手術的需求不斷增長,預計移動 C 臂細分市場將在預測期內實現顯著增長。

北美將佔據很大的市場份額,預計在預測期內也會如此

由於慢性病和遺傳病患病率上升、醫療保健基礎設施和缺乏報銷等因素,預計北美的手術影像市場將出現增長。 例如,根據美國癌症協會的 2022 年更新,2022 年美國將診斷出 1,918,030 例新的癌症病例。 根據同一消息來源,2022 年美國將診斷出 268,490 例前列腺癌病例。 因此,由於慢性病的高患病率,預計對手術成像的需求將增加,這有望在預測期內推動市場增長。

此外,微創手術的需求正在上升,預計在預測期內將推動研究區域的市場增長。 例如,2022年5月,TRiCares在加拿大推出微創Topaz三尖瓣置換系統。 此外,2021 年 5 月,KA Imaging 宣布已與 Bio Scan S.A. de C.V.簽署墨西哥分銷協議。 作為墨西哥的總銷售代理,Bio Scan 將與 KA Imaging 全面合作,提供銷售和支持。

此外,與手術成像領域相關的競爭對手的存在、產品發布和批准預計將在預測期內推動市場增長。 例如,2021 年 12 月,經 FDA 批准的便攜式磁共振成像 MRI 機器 Swoop 的創建者 Hyperfine, Inc. 在成像系統在加拿大商業發布的同時獲得了加拿大衛生部的 Swoop 許可。 此外,2021 年 2 月,南岸地區醫院重建項目將開始,政府將資助南岸地區醫院安裝新的磁共振成像 (MRI) 掃描儀。

因此,由於慢性病的高患病率和對手術成像的需求不斷增加,所研究的市場在預測期內可能會在北美地區出現增長。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 對微創手術的需求不斷擴大
    • 慢性病負擔加重
  • 市場製約因素
    • 高昂的手術和設備費用
    • 嚴格的監管準則
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第五章市場細分(價值基礎,單位:百萬美元)

  • 通過成像技術
    • 磁共振成像
    • 計算機斷層掃描
    • C型臂
      • 固定式 C 型臂
      • 移動式 C 型臂
    • 超聲診斷設備
    • 其他圖像處理技術
  • 通過申請
    • 心臟外科、血管外科
    • 神經外科
    • 整形外科/外傷外科
    • 消化外科
    • 其他應用
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Canon Medical Systems Corporation
    • General Electric Company(GE Healthcare)
    • Geonoray Co. Ltd
    • Hologic Inc.
    • Koninklijke Philips NV
    • Medtronic plc
    • Orthoscan Inc.
    • Seimens AG
    • Shimadzu Corporation
    • Ziehm Imaging

第七章市場機會與未來趨勢

簡介目錄
Product Code: 60444

The surgical imaging market is expected to register a CAGR of 6.1% over the forecast period.

During the initial phase of the COVID-19 pandemic, there was a severe reduction in the number of medical imaging services provided all over the world, owing to the fear of the risk of contamination, and the non-availability of certain imaging agents, such as radiotracers, which heavily impacted the growth of the market. For instance, as per the article published in November 2021 in PubMed, the COVID-19 epidemic resulted in a considerable decrease in radiology imaging and procedures. The overall reduction in radiology services was determined by the stage/period of lockdown, location, and imaging modality. As per the same source, a 76% reduction in ultrasound, 74 % reduction in MRI, and 66% reduction in mammography were reported. However, in the post-pandemic situation, as the restrictions are lifted, the market is gaining demand due to the advancements in surgical imaging techniques and the need for diagnostic imaging for chronic diseases.

Over the last decade, there has been a rise in the prevalence of several chronic diseases that need critical care diagnosis. The patients in the surgical intensive care unit frequently undergo laboratory and imaging testing. Several chronic diseases, such as hypertension, diabetes, obesity, and depression, amongst others, need critical care during their hospitalizations. The high prevalence of cardiovascular disorders is expected to boost the demand for surgical imaging services, thereby propelling the market growth. For instance, according to the 2022 UK Factsheet by BHF, over 7.6 million people in the United Kingdom were living with heart and circulatory diseases as of August 2022. The factsheet indicated that heart and circulatory diseases cost the nation over EUR 9 billion (USD 7.6 billion) every year. Moreover, the large population affected by cardiovascular diseases along with the associated high annual healthcare costs are expected to boost the growth of the studied market over the forecast period. Also, chronic obstructive pulmonary disease (COPD), a type of respiratory disease is chronic inflammation in the lungs that causes obstructed airflow from the lungs. The disease is generally diagnosed with the help of chest X-ray, CT, and magnetic resonance imaging (MRI). According to the research briefing by the United Kingdom House of Commons published in November 2021, there were over 1.17 million people in England who had been diagnosed with COPD, accounting for around 1.9% of the population. The huge population affected by COPD increases the demand for surgical imaging services for proper therapy and management, thereby propelling market growth over the forecast period.

Furthermore, product launches, the presence of competitors, mergers, and acquisitions relating to the surgical imaging field are likely to boost the market growth over the forecast period. For instance, in July 2022, Siemens Healthineers received approval from the FDA for the ARTIS icono ceiling, a ceiling-mounted C-arm angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. Furthermore, in April 2022, Wipro GE Healthcare, a medical technology, and digital solutions innovator launched its next-generation Revolution Aspire CT (Computed Tomography) scanner. Revolution Aspire is designed and manufactured end-to-end in India, at the newly launched Wipro GE Medical Devices Manufacturing plant, in line with the 'Atmanirbhar Bharat' initiative. Hence, such product launches associated with the surgical imaging field are likely to boost market growth over the forecast period.

Hence, due to the rise in chronic diseases and the increase in demand for minimally invasive procedures, the market for surgical imaging is anticipated to grow over the forecast period. However, the high procedural and equipment costs and the stringent regulatory guidelines are expected to restrict the market growth during the forecast period.

Surgical Imaging Market Trends

Mobile C-Arm Segment is Believed to Witness Rapid Growth Over the Forecast Period in the Surgical Imaging Market

A mobile C-arm is a medical imaging device that uses X-ray technology and can be utilized in a variety of operation rooms across a clinic. The term is derived from the C-shaped arm that connects the X-ray source and X-ray detector. One of the major advantages of C-arms is the ability to move around the patient for achieving the optimum angle for a high-quality image while keeping the patient comfortable. These factors are ideal for smaller hospitals with significant cost constraints.

Factors such as the rise in the prevalence of chronic diseases, and growing demand for minimally invasive procedures are likely to boost the market growth. For instance, as per the 2022 update from Brast Cancer.org, about 13% (about 1 in 8) of U.S. women are likely to develop invasive breast cancer in 2022. As per the same source, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive (in situ) breast cancer. Hence, as the number of chronic cases increases, the demand for mobile C-arm rises and thereby boosting the market growth over the forecast period.

Moreover, the presence of key players, mergers, acquisitions, and product launches in the mobile C-arm field is likely to boost the market growth over the forecast period. For instance, in January 2022, Philips integrated cloud-based artificial intelligence and 3D mapping into its Mobile C-arm System Series, Zenition, to enhance workflow efficiency and improve endovascular treatment outcomes. Furthermore, in June 2021, Turner Imaging Systems received its CE Mark for its Smart-C Mini C-Arm portable fluoroscopy X-ray imaging device. This was anticipated to allow the Smart-C, a highly portable mini C-arm, to be distributed throughout the EU countries as well as the UK.

As a result, due to the rise in the prevalence of chronic diseases, and the growing demand for minimally invasive procedures, the mobile c-arm segment is expected to register significant growth during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to witness growth in the surgical imaging market owing to the factors such as the rising prevalence of chronic diseases and genetic disorders as well as the presence of healthcare infrastructure and reimbursement availability. For instance, as per the American Cancer Society 2022 update, the number of new cancer cases diagnosed in the United States is likely to be 1,918,030 in 2022. As per the same source, 268,490 cases of prostate cancer are likely to be diagnosed in the United States in 2022. Hence, due to the high prevalence of chronic disease, there is likely to be a rise in demand for surgical imaging, which is anticipated to boost market growth over the forecast period.

Moreover, the demand for minimally invasive procedures is on the rise, which is anticipated to boost the market growth in the studied region over the forecast period. For instance, in May 2022, TRiCares implemented of minimally invasive Topaz Tricuspid Heart Valve replacement system in Canada. Furthermore, in May 2021, KA Imaging announced a distribution agreement with Bio Scan S.A. de C.V. in Mexico. Bio Scan, as the sole distributor in Mexico, the company was likely to be responsible for sales and support in full collaboration with KA Imaging territory-wide.

Additionally, the presence of competitors, product launches, and approvals associated with the surgical imaging field is likely to drive market growth over the forecast period. For instance, in December 2021, Hyperfine, Inc., creator of the FDA-cleared portable magnetic resonance imaging MRI device, Swoop received Health Canada licensing of Swoop as well as the commercial launch of the imaging system in Canada. Furthermore, in February 2021, South Shore Regional Hospital Redevelopment Project was launched under which the government has funded a new Magnetic Resonance Imaging (MRI) scanner for the South Shore Regional Hospital.

Thus, due to the high prevalence of chronic diseases and the rise in demand for surgical imaging, the studied market is likely to witness growth in the North America region over the forecast period.

Surgical Imaging Market Competitor Analysis

The surgical imaging market is moderately competitive and consists of several global players. As the market is progressing, the firms are trying to achieve clear differentiation in surgical imaging systems, based on their application. Due to the requirements for high-quality imaging and operative capabilities, various customer groups are shifting toward optimized surgical imaging systems. Major players are Canon Medical Systems Corporation, Medtronic Plc, Hologic Inc, and General Electric Company (GE healthcare) among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand of Minimally Invasive Procedures
    • 4.2.2 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Procedural and Equipment Costs
    • 4.3.2 Stringent Regulatory Guidelines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Imaging Technology
    • 5.1.1 Magnetic resonance imaging
    • 5.1.2 Computed Tomography
    • 5.1.3 C-Arm
      • 5.1.3.1 Fixed C-Arm
      • 5.1.3.2 Mobile C-Arm
    • 5.1.4 Ultrasound
    • 5.1.5 Other Imaging Technologies
  • 5.2 By Application
    • 5.2.1 Cardiac and Vascular Surgery
    • 5.2.2 Neurosurgery
    • 5.2.3 Orthopedic and Trauma Surgery
    • 5.2.4 Gastrointestinal Surgery
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 General Electric Company (GE Healthcare)
    • 6.1.3 Geonoray Co. Ltd
    • 6.1.4 Hologic Inc.
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Medtronic plc
    • 6.1.7 Orthoscan Inc.
    • 6.1.8 Seimens AG
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Ziehm Imaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS